Venous thromboembolism in men and women

Journal of Men's Health and Gender

Volumn 2, Issue 3, 2005, Pages 302-308

  Kyrle, Paul A ^a   Eichinger, Sabine ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Gender; Pulmonary embolism; Risk factors; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; BLOOD CLOTTING FACTOR 10A INHIBITOR; D DIMER; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; ORAL CONTRACEPTIVE AGENT;

AGE; ANTICOAGULATION; ANTITHROMBIN DEFICIENCY; BLEEDING; BLOOD CLOT LYSIS; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BRAIN HEMORRHAGE; CANCER; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DRUG WITHDRAWAL; DYSFIBRINOGENEMIA; ECHOGRAPHY; FREQUENCY ANALYSIS; HIGH RISK PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; INCIDENCE; INFERIOR CAVA VEIN; INHERITANCE; INJURY; LONG TERM CARE; LUNG EMBOLISM; MEDICAL ASSESSMENT; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN DEFICIENCY; RECURRENT DISEASE; REVIEW; SEX; THORAX; THROMBECTOMY; VENA CAVA FILTER; VENOUS THROMBOEMBOLISM;

EID: 28744447713     PISSN: 15718913     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhg.2005.04.002     Document Type: Review

References (45)

1. F.A. Anderson, H.B. Wheeler, R.J. Goldberg, D.W. Hosmer, N.A. Patwardhan, and B. Jovanovic A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study Arch Intern Med 151 1991 933 938
2. M. Nordström, B. Lindblad, D. Bergqvist, and T. Kjellström A prospective study of the incidence of deep-vein thrombosis within a defined urban population J Intern Med 232 1992 155 160
3. W.D. Kniffin Jr., J.A. Baron, J. Barrett, J.D. Birkmeyer, and F.A. Anderson Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly Arch Intern Med 154 1994 861 866
4. R.F. Gillum Pulmonary embolism and thrombophlebitis in the United States, 1970-1985 Am Heart J 114 1987 1262 1264
5. D.E. Lilienfeld, J.H. Godbold, G.L. Burke, J.M. Sprafka, D.L. Pham, and J. Baxter Hospitalization and case fatality or pulmonary embolism in the Twin Cities: 1979-1984 Am Heart J 120 1990 392 395
6. E. Oger Incidence of venous thromboembolism: a community-based study in Western France Thrombosis and Haemostasis 83 2000 657 660
7. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, C.M. Lohse, and W.M. O'Fallon The epidemiology of venous thromboembolism in the community Thrombosis and Haemostasis 86 2001 452 463
8. A.W. Tsai, M. Cushman, W.D. Rosamond, S.R. Heckbert, J.F. Polak, and A.R. Folsom Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology Arch Intern Med 162 2002 1182 1189
9. P.A. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann, and S. Eichinger The risk of recurrent venous thromboembolism in men and women N Engl J Med 350 2004 2558 2563
10. T. Baglin, R. Luddington, K. Brown, and C. Baglin High risk of recurrent venous thromboembolism in men Journal of Thrombosis and Haemostasis 2 2004 2152 2155
11. J.A. Nieto, M. Monreal or the RIETE investigators Recurrent venous thromboembolism in men and women N Engl J Med 351 2004 2016 2017
12. P.A. Kyrle, and S. Eichinger The risk of recurrent venous thromboembolism Vasa 31 2002 163 166
13. T. Koster, A.D. Blann, E. Briet, J.P. Vandenbroucke, and F.R. Rosendaal Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis Lancet 345 1995 152 155
14. A. van Hylckama Vlieg, I.K. van der Linden, R.M. Bertina, and F.R. Rosendaal High levels of factor IX increase the risk of venous thrombosis Blood 95 2000 3678 3682
15. J.C. Meijers, W.L. Tekelenburg, B.N. Bouma, R.M. Bertina, and F.R. Rosendaal High levels of coagulation factor XI as a risk factor or venous thrombosis N Engl J Med 342 2000 696 701
16. S. Eichinger, A. Weltermann, E. Minar, M. Stain, V. Schönauer, and B. Schneider Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism Arch Intern Med 164 2004 92 96
17. C. Kearon, M. Gent, J. Hirsh, J. Weitz, M.J. Kovacs, and D.R. Anderson A comparison of three months of anticoagulation with extended anticoagulation or a first episode of idiopathic venous thromboembolism N Engl J Med 340 1999 901 907
18. Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thrombosis and Haemostasis 1999;81:84-9.
19. V. De Stefano, I. Martinelli, P.M. Mannucci, K. Paciaroni, P. Chiusolo, and I. Casorelli The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N Engl J Med 341 1999 801 806
20. S. Eichinger, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain, and C. Mannhalter The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene Thrombosis and Haemostasis 81 1999 14 17
21. M.A. Khamashta, M.J. Cuadrado, F. Mujic, N.A. Taub, B.J. Hunt, and G.R. Hughes The management of thrombosis in the antiphospholipid-antibody syndrome N Engl J Med 332 1995 993 997
22. S. Schulman, E. Svenungsson, and S. Granqvist Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy Am J Med 104 1998 332 338
23. P.A. Kyrle, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain, and B. Schneider High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 2000 457 462
24. P. Prandoni, A.W. Lensing, A. Cogo, S. Cuppini, S. Villalta, and M. Carta The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1 7
25. M. Margaglione, G. D'Andrea, D. Colaizzo, G. Cappucci, A. del Popolo, and V. Brancaccio Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism Thrombosis and Haemostasis 82 1999 1583 1587
26. P.S. Wells, D.R. Anderson, J. Bormanis, F. Guy, M. Mitchell, and L. Gray Application of a diagnostic clinical model or the management of hospitalized patients with suspected deep-vein thrombosis Thrombosis and Haemostasis 81 1999 493 497
27. P.S. Wells, D.R. Anderson, M. Rodger, J.S. Ginsberg, C. Kearon, and M. Gent Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer Thrombosis and Haemostasis 83 2000 416 420
28. P.S. Wells, D.R. Anderson, M. Rodger, M. Orgie, C. Kearon, and J. Dreyer Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis N Engl J Med 349 2003 1227 1235
29. K.L. Dunn, J.P. Wolf, D.M. Dorfman, P. Fitzpatrick, J.L. Baker, and S.Z. Goldhaber Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism J Am Coll Cardiol 40 2002 1475 1478
30. A.W. Lensing, P. Prandoni, D. Brandjes, P.M. Huisman, M. Vigo, and G. Tomasella Detection of deep-vein thrombosis by real-time B-mode ultrasonography N Engl J Med 320 1989 342 345
31. R. Quintavalla, P. Larini, A. Miselli, R. Mandrioli, U. Ugolotti, and C. Pattacini Duplex ultrasound diagnosis of symptomatic proximal deep vein thrombosis of lower limbs European Journal of Radiology 15 1992 32 36
32. PIOPED Investigators Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the prospective investigation of pulmonary embolism diagnosis (PIOPED) JAMA 263 1990 2753 2759
33. M.J. Van Strijen, W. de Monye, G.J. Kieft, P.M. Pattynama, M.H. Prins, and M.V. Huisman Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy Journal of Thrombosis and Haemostasis 3 2005 17 25
34. M.K. Gould, A.D. Dembitzer, R.L. Doyle, T.J. Hastie, and A.M. Garber Low-molecular-weight heparins compared with unfractionated heparin or treatment of acute deep venous thrombosis Ann Intern Med 130 1999 800 809
35. L.R. Dolovich, J.S. Ginsberg, J.D. Douketis, A.M. Holbrook, and G. Cheah A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism Arch Intern Med 160 2000 181 188
36. Van Dongen CJ, Mac Gillavry MR, Prins MH. Once versus twice daily LMWH or the initial treatment of venous thromboembolism (Cochrane review). The Cochrane Library, Issue 3, 2004. Chichester, UK: John Wiley & Sons, Ltd.
37. J.B. Segal, D.T. Bolger, M.W. Jenckes, J.A. Krishnan, M.B. Streiff, and J. Eng Outpatient therapy with low molecular weight heparin or the treatment of venous thromboembolism: a review of efficacy, safety, and costs Am J Med 115 2003 298 308
38. Watson LI, Armon MP. Thrombolysis or acute deep vein thrombosis: The Cochrane Database of Systematic Reviews 2004. Issue 3. Art. No.: CD002783.pub2. DOI: 10.1002/14651858.CD002783.pub2.
39. S.Z. Goldhaber Pulmonary embolism Lancet 363 2004 1295 1305
40. H. Decousus, A. Leizorovicz, F. Parent, Y. Page, B. Tardy, and P. Girard A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group N Engl J Med 338 1998 409 415
41. C. Kearon, J.S. Ginsberg, D.R. Anderson, M.J. Kovacs, P. Wells, J.A. Julian SOFAST Investigators Comparison of 1 month with 3 months of anticoagulation or a first episode of venous thromboembolism associated with a transient risk factor Journal of Thrombosis and Haemostasis 2 2004 743 749
42. L. Pinede, J. Ninet, P. Duhaut, S. Chabaud, S. Demolombe-Rague, I. Durieu Investigators of the "Duree Optimale du Traitement AntiVitamines K" (DOTAVK) Study Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis Circulation 103 2001 2453 2460
43. G. Agnelli, P. Prandoni, M.G. Santamaria, P. Bagatella, A. Iorio, M. Bazzan Warfarin Optimal Duration Italian Trial Investigators Three months versus one year of oral anticoagulant therapy or idiopathic deep venous thrombosis N Engl J Med 345 2001 165 169
44. P. Prandoni, A.W. Lensing, A. Piccioli, E. Bernardi, P. Simioni, and B. Girolami Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 2002 3484 3488
45. A.Y. Lee, M.N. Levine, R.I. Baker, C. Bowden, A.K. Kakkar, M. Prins Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy or the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators Low-molecular-weight heparin versus a coumarin or the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146 153